Tropical Journal of Pharmaceutical Research

Original Research Article | OPEN ACCESS

Effect of Wuling powder on the pharmacokinetics of valproic acid in epileptic rats

Yujun Qiao¹, Yuting Liu², Chen Jia³, Rui Zhang¹, Wen Yin³, Aijia Cao³, Jiali Zhang³, Haisheng Jiao³

¹College of Pharmacy, Lanzhou University; ²Hengrui Medicine Co. Ltd; ³Department of Pharmacy, Lanzhou University Second Hospital, Lanzhou, China.

For correspondence:- Haisheng Jiao Email: Haisjiao@163.com

Accepted: 25 October 2020 Published: 30 November 2020

Citation: Qiao Y, Liu Y, Jia C, Zhang R, Yin W, Cao A, et al. Effect of Wuling powder on the pharmacokinetics of valproic acid in epileptic rats. Trop J Pharm Res 2020; 19(11):2425-2432 doi: 10.4314/tjpr.v19i11.25

© 2020 The authors.
This is an Open Access article that uses a funding model which does not charge readers or their institutions for access and distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0) and the Budapest Open Access Initiative (http://www.budapestopenaccessinitiative.org/read), which permit unrestricted use, distribution, and reproduction in any medium, provided the original work is properly credited..

Abstract

Purpose: To investigate the effect of Wuling powder (WP) on the pharmacokinetics of valproic acid (VPA) in epileptic rats.

Methods: A model of epilepsy was established in SD rats by intraperitoneal injection of pentylenetetrazole (PTZ). Twelve epileptic rats were randomly divided into two groups: control group given oral VPA alone at a dose of 180 mg/kg VPA, and drug combination group orally given VPA (180 mg/kg) co-administered with WP at a dose of 200 mg/kg. Blood sample (0.5 mL) was collected at 15, 30, 60, 120, 240 and 720 min after drug administration for measurement of plasma concentrations of VPA using ultraperformance liquid chromatography-tandem mass spectrometry (UPLC-MS/MS).

Results: The AUC (0-480min) and maximum plasma concentrations (C_max) of VPA in the drug combination group were significantly higher than those in the control group (p < 0.01). The half-time (t_1/2) and time taken to attain maximum plasma VPA concentration (T_max) in the combination group were extended, when compared to control group (p < 0.05).

Conclusion: These results demonstrate that WP increases the plasma concentration of VPA and affects the pharmacokinetic properties of VPA in epileptic rats. Thus, the pharmacodynamic influence of this interaction should be taken into consideration while prescribing WP to epileptic patients already taking VPA.

Keywords: Wuling powder, Valproic acid, Pharmacokinetics, Epilepsy